Form 4: Hinge Health Director Plans Future Stock Sale

Hinge Health Director Kristina M. Leslie reported a pre-planned sale of 1,250 shares of Class A Common Stock scheduled for November 21, 2025.

Summary

• Kristina M. Leslie, a Director of Hinge Health, Inc. (HNGE), reported a planned disposition of Class A Common Stock.
• The transaction involves the sale of 1,250 shares, scheduled for November 21, 2025.
• The shares are planned to be sold at a weighted average price of $45.6848 per share, with prices ranging from $45.68 to $45.71.
• Following this planned transaction, Ms. Leslie will beneficially own 27,750 shares of Class A Common Stock directly.
• The transaction is made pursuant to a Rule 10b5-1(c) plan, indicating it is a pre-scheduled and automated sale.

Sentiment

Score: 5

Explanation: Neutral. The transaction is a routine, pre-planned sale by a director scheduled for a future date, which typically does not carry significant positive or negative implications for the company's fundamental outlook.

Negatives

• A planned reduction in insider ownership by 1,250 shares, although routine due to a 10b5-1 plan, can sometimes be perceived as a slight negative by some investors.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Kristina M. Leslie, a Director of Hinge Health, Inc., plans to sell 1,250 shares of the company's Class A Common Stock.

Stakeholder Impact

• Shareholders: A minor, pre-planned reduction in insider ownership, which is generally considered routine and not indicative of new material information.

Key Dates

Recommendation

The planned sale of 1,250 shares by Director Kristina M. Leslie is scheduled for a future date and was executed under a pre-arranged Rule 10b5-1 plan. Such transactions are generally for personal financial planning purposes and do not reflect a change in the company's fundamental outlook or new material information. Therefore, this filing alone does not provide a basis to alter an existing investment thesis, leading to a 'hold' recommendation.

Keywords

Hinge Health, HNGE, Form 4, insider trading, stock sale, director, beneficial ownership, Class A Common Stock, 10b5-1 plan